Psilocybin-assisted treatment for long-term body pain
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system, Pain clinical trials.
This early trial studies whether psilocybin, given in a supported setting, can reduce long-term widespread musculoskeletal pain (including fibromyalgia-like symptoms). You would be monitored closely and need someone to take you home after the medicine session.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 25 and 65 years old
- Your widespread body pain has lasted 12 months or more
- Your symptoms fit fibromyalgia criteria used in 2016 diagnostic guidelines
- You can travel to the UAB study site for all scheduled visits
- Your average pain is at least 5 out of 10 each day
- You have a friend or family member who can stay responsible for you after dosing (including driving you home)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether psilocybin, a substance found in certain mushrooms, can help reduce pain in people with fibromyalgia. You would receive the drug and be monitored closely to see if it improves your pain levels.
This trial tests if psilocybin, a psychedelic drug, can help people with long-term low back pain who also have depression. If you qualify, you'll receive psilocybin in a controlled setting, and researchers will see how it affects your pain and mood.
This study tests whether psilocybin (a compound found in certain mushrooms) can help reduce chronic nerve pain that has not responded well to standard medications. You will receive study treatment plus psychotherapy to see if it improves your pain.
This study tests whether a single dose of psilocybin (the active ingredient in 'magic mushrooms') combined with physical therapy can help relieve chronic low back pain. It aims to see if this approach can reduce pain and improve your ability to do daily activities.
This trial tests if a single dose of psilocybin (a psychedelic drug from certain mushrooms) given with psychological support can help reduce long-term pain in people with cancer who are already taking opioid painkillers.
This trial tests whether MDMA (a drug sometimes called 'ecstasy') can help people with fibromyalgia when used alongside therapy sessions. The goal is to see if it reduces pain and improves quality of life.
Hear when a new Fibromyalgia, Primary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.